Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles

PloS One
Camille TumiottoHervé Fleury

Abstract

One of the approaches by which the scientific community is seeking to cure HIV is the use of therapeutic vaccination. Previous studies have highlighted the importance of the virus-specific CD8+ T cell cytotoxic responses for the immune control of HIV and have oriented research on vaccine constructs based on CTL epitopes from circulating HIV-1 strains. The clinical trials with therapeutic vaccines to date have had limited success likely due to (i) a discrepancy between archived CTL epitopes in the viral reservoir and those in circulating viruses before antiretroviral therapy (ART) initiation and (ii) the lack of strong affinity between the selected CTL epitopes and the HLA grooves for presentation to CD8+ cells. To overcome these limitations, we launched the Provir/Latitude 45 study to identify conserved CTL epitopes in archived HIV-1 DNA according to the HLA class I alleles of aviremic patients, most of whom are under ART. The near full-length genomes or Gag, Pol and Nef regions of proviral DNA were sequenced by Sanger and/or Next Generation Sequencing (NGS). The HLA-A and B alleles were defined by NGS or molecular analysis. The TuTuGenetics software, which moves a sliding window of 8 to 10 amino acids through the amino acid al...Continue Reading

References

Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·John SidneyAlessandro Sette
Dec 14, 2011·Journal of Translational Medicine·Beatriz MotheChristian Brander
Sep 25, 2012·Cold Spring Harbor Perspectives in Medicine·Bruce Walker, Andrew McMichael
Jun 25, 2013·Virology·Lindsay M EyzaguirreMohammad M Sajadi
Nov 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Lina JosefssonSarah Palmer
Apr 4, 2015·Human Vaccines & Immunotherapeutics·Yi YangYusen Zhou
Jan 6, 2016·The Journal of Clinical Investigation·R Brad Jones, Bruce D Walker
Feb 2, 2016·The Journal of Clinical Investigation·Janet D Siliciano, Robert F Siliciano
Jul 12, 2016·Nature Medicine·Steven G DeeksJerome Zack
Jul 20, 2016·Proceedings of the National Academy of Sciences of the United States of America·Hiromi ImamichiH Clifford Lane
Oct 30, 2016·Science·Debattama R SenW Nicholas Haining
Nov 18, 2016·ELife·Johanna BrodinJan Albert
Apr 19, 2017·Proceedings of the National Academy of Sciences of the United States of America·Ann WiegandMary F Kearney
Sep 9, 2017·AIDS Research and Human Retroviruses·Shahzada KhanShomyseh Sanjabi
Sep 14, 2017·AIDS Research and Human Retroviruses·Herve FleuryPatricia Recordon-Pinson
Sep 22, 2017·PloS One·Camille TumiottoUNKNOWN Provir/Latitude 45 collaborating group
Jul 22, 2018·Advances in Experimental Medicine and Biology·Beatriz Mothe, Christian Brander

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry
Assay
chip

Software Mentioned

HLA
TutuGenetics
Smartgene
Twin

Related Concepts